Found 29 matching trials
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
PHASE1This is a Phase 1, first-in-human study designed to assess the safety, tole...
Location
ICON Early Phase Services/CRU
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
PHASE1A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and ...
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
NAPatients undergoing open heart surgery are at risk of suffering damage to t...
Status
Active Not Recruiting
Location
Rigshospitalet - Copenhagen University Hospital
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
PHASE4The aim of this study is to detail the (mechanisms underlying the) actions ...
Location
VU University Medical Center
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
PHASE4The primary goal of this study is to determine the acute effects of exenati...
Location
Phoenix VA Medical Center
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
NAThe study seeks to explore the cardiovascular effects of co-agonism at two ...
Location
Addenbrooke's Hospital
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
NAThe purpose of this study is to explore whether the GLP-1 receptor agonist ...
Location
VU University Medical Center
Exenatide Once Weekly for Smoking Cessation
PHASE1The purpose of this study is to identify a potential new treatment for smok...
Location
The University of Texas Health Science Center at Houston
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
NAExperimental studies and previous clinical trials suggest neuroprotective e...
Location
Kardiologisk Afdeling, Rigshospitalet
Exenatide for Smoking Cessation and Prevention of Weight Gain
PHASE2The purpose of this study is to determine if exenatide improves end-of-trea...
Location
Michael E. DeBakey VA Medical Center